Search results for "navi"

showing 10 items of 1983 documents

SARS-CoV2 vertical transmission with adverse effects on the newborn revealed through integrated immunohistochemical, electron microscopy and molecula…

2020

Background: The occurrence of trans-placental transmission of severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) infection remains highly debated. Placental positivity for SARS-CoV-2 has been reported in selected cases, but infection or virus-associated disease of fetal tissues or newborns remains to be demonstrated. Methods: We screened for SARS-CoV-2 spike (S) protein expression placentas from 101 women who delivered between February 7 and May 15 2020, including 15 tested positive for SARS-CoV-2 RNA, 34 tested negative, and 52 not evaluated as they did not meet testing criteria (32), or delivered before COVID-19 pandemic declaration (20). Immunostain for SARS-CoV-2 nucleocapsid…

0301 basic medicinePathologyCOVID19Placentaviruseslcsh:MedicineExtracellular Traps0302 clinical medicinePregnancyNasopharynxPathology MolecularPregnancy Complications InfectiousAdult Betacoronavirus COVID-19 Coronavirus Infections Coronavirus Nucleocapsid Proteins Female Humans Immunohistochemistry Infant Newborn Spike Glycoprotein Coronavirus Microscopy Electron Nasopharynx PregnancySpike Glycoprotein CoronavirusSARS-CoV-2lcsh:R5-920medicine.diagnostic_testIntervillous spaceGeneral MedicineNucleocapsid ProteinsImmunohistochemistrymedicine.anatomical_structure030220 oncology & carcinogenesisSpike Glycoprotein CoronavirusRNA ViralFemaleCoronavirus Infectionslcsh:Medicine (General)Adultmedicine.medical_specialtyPneumonia ViralIn situ hybridizationSettore MED/08 - Anatomia PatologicaBiologyImmunofluorescenceArticleGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciencesBetacoronavirusSyncytiotrophoblastImmune systemAntigenPlacentamedicineSettore MED/05 - Patologia ClinicaCoronavirus Nucleocapsid ProteinsHumansPandemicsPregnancyFetusbusiness.industrySARS-CoV-2Macrophageslcsh:RInfant NewbornCOVID-19medicine.diseasePhosphoproteinsInfectious Disease Transmission VerticalMicroscopy Electron030104 developmental biologybusinessEBioMedicine
researchProduct

Potential Influence of Helminth Molecules on COVID-19 Pathology

2020

In recent months, the parasitology research community has been tasked with investigation of the influence of parasite coinfection on coronavirus disease 2019 (COVID-19) outcomes. Herein, we share our approach to analyze the effect of the trematode Fasciola hepatica as a modulator of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and of COVID-19 pathology.

0301 basic medicinePathologymedicine.medical_specialtyFascioliasisCoronavirus disease 2019 (COVID-19)Helminth proteinSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)viruses030231 tropical medicineInfection modulation03 medical and health sciences0302 clinical medicineAntigenic ModulationPathology modulationparasitic diseasesMedicineParasite hostingFasciola hepaticaHelminthsAnimalsHumansImmunologic FactorsInflammationHelminth parasitesRespiratory Distress SyndromebiologyForumbusiness.industryCoinfectionvirus diseasesCOVID-19Helminth ProteinsFasciola hepaticamedicine.diseasebiology.organism_classificationImmunity Innate030104 developmental biologyInfectious DiseasesParasitologyCoinfectionParasitologybusinessTrends in Parasitology
researchProduct

Impact of COVID-19 on global HCV elimination efforts.

2021

Background & Aims COVID-19 has placed significant strain on national healthcare systems at a critical moment in the context of hepatitis elimination. Mathematical models can be used to evaluate the possible impact of programmatic delays on hepatitis disease burden. The objective of this analysis was to evaluate the incremental change in hepatitis C liver-related deaths and liver cancer, following a 3-month, 6-month, or 1-year hiatus in hepatitis elimination program progress. Methods Previously developed models were adapted for 110 countries to include a status quo or “no delay” scenario and a “1-year delay” scenario assuming significant disruption in interventions (screening, diagnosis and …

0301 basic medicinePsychological interventioncoronavirusUMIC upper-middle income countriesGlobal HealthUI uncertainty intervalHIC high income countries0302 clinical medicineCost of IllnessLIC low income countriesMedicineUSA United States of AmericaLetter to the EditorMathematical modellingPWID people who inject drugsLiver DiseaseLiver DiseasesVaccinationmathematical modelingGBD Global Burden of DiseaseHepatitis CSVR sustained virologic responseEuropeHCV hepatitis C virusHepatocellular carcinomaHCVGHSS Global Health Sector StrategyRNA Viral030211 gastroenterology & hepatologyAMR region of the AmericasLiver cancerViral hepatitisHumanCarcinoma HepatocellularCoronavirus disease 2019 (COVID-19)EMR Eastern Mediterranean regionViral hepatitis eliminationviral hepatitisContext (language use)World Health OrganizationArticleWHO World Health OrganizationTime-to-Treatment03 medical and health scienceseliminationEnvironmental healthHumansLMIC lower-middle income countriesDisease EradicationDisease burdenHepatitisHepatologySARS-CoV-2business.industryWPR Western Pacific regionCOVID-19Models Theoreticalmedicine.diseaseCost of Illne030104 developmental biologySpainHCC hepatocellular carcinomabusinessJournal of hepatology
researchProduct

Cosavirus, Salivirus and Bufavirus in Diarrheal Tunisian Infants

2016

International audience; Three newly discovered viruses have been recently described in diarrheal patients: Cosa-virus (CosV) and Salivirus (SalV), two picornaviruses, and Bufavirus (BuV), a parvovirus. The detection rate and the role of these viruses remain to be established in acute gastroen-teritis (AGE) in diarrheal Tunisian infants. From October 2010 through March 2012, stool samples were collected from 203 children <5 years-old suffering from AGE and attending the Children's Hospital in Monastir, Tunisia. All samples were screened for CosV, SalV and BuV as well as for norovirus (NoV) and group A rotavirus (RVA) by molecular biology. Positive samples for the three screened viruses were …

0301 basic medicineRNA virusesMaleRotavirusViral DiseasesHuman astrovirusesIdentificationvirusesEnteric viruseslcsh:MedicinePolymerase chain-reactionArtificial Gene Amplification and ExtensionPicornaviridaemedicine.disease_causePathology and Laboratory MedicinePolymerase Chain ReactionPediatricsReverse-transcription-pcrlaw.inventionParvoviruslaw[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseasesRotavirusMedicine and Health Scienceslcsh:ScienceChildrenPolymerase chain reactionPhylogenyMultidisciplinarybiologyTransmission (medicine)[ SDV.IDA ] Life Sciences [q-bio]/Food engineeringPhylogenetic Analysis3. Good healthGastroenteritisInfectious DiseasesMedical MicrobiologyViral PathogensChild PreschoolViruses[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/VirologyFemalePathogensAichi virusPediatric InfectionsResearch ArticleDiarrheaTunisia030106 microbiologyGastroenterology and HepatologyResearch and Analysis MethodsMicrobiologyCalicivirusesAstrovirus03 medical and health sciencesKlassevirusParvovirusesAdeno-Associated VirusesmedicineHumansMolecular Biology TechniquesMolecular BiologyMicrobial PathogensRotavirus InfectionMolecular Biology Assays and Analysis TechniquesParvovirusNoroviruslcsh:ROrganismsBiology and Life SciencesInfantSapovirusReverse Transcriptase-Polymerase Chain Reactionbiology.organism_classificationVirology030104 developmental biologyNoroviruslcsh:QDNA viruses
researchProduct

Ortervirales: New Virus Order Unifying Five Families of Reverse-Transcribing Viruses

2018

International audience; Reverse-transcribing viruses, which synthesize a copy of genomic DNA from an RNA template, are widespread in animals, plants, algae, and fungi (1, 2). This broad distribution suggests the ancient origin(s) of these viruses, possibly [...]

0301 basic medicineS1retrovirusesviruses[SDV]Life Sciences [q-bio]ImmunologyretroviridaeMESH: Reverse TranscriptionL73 - Maladies des animauxVirus Replication[SDV.BID.SPT]Life Sciences [q-bio]/Biodiversity/Systematics Phylogenetics and taxonomyMicrobiologyVirusbelpaoviridaeMESH: Viruses03 medical and health sciencesVirologyinternational committee on taxonomy of viruses (ICTV)Metaviridaevirus classificationLetter to the EditorVirus classificationGeneticsTy3/Gypsy and Ty1/Copia LTR retrotransposonscaulimoviridaevirus evolutionbiologyfungiMESH: Virus ReplicationRNAPseudoviridaeReverse Transcriptionbiology.organism_classificationMESH: Caulimoviridaegenomic DNA030104 developmental biologyMESH: RetroviridaeMESH: HepadnaviridaeInsect ScienceViral evolutionhepadnaviridaeBelpaoviridae; Caulimoviridae; Hepadnaviridae; International Committee on Taxonomy of Viruses (ICTV); Metaviridae; Pseudoviridae; Retroviridae; Ty3/Gypsy and Ty1/Copia LTR retrotransposons; retroviruses; virus classification; virus evolutionViruses[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/VirologymetaviridaeCaulimoviridaepseudoviridae
researchProduct

Demo

2017

We present an innovative smartphone-centric tracking system for indoor and outdoor environments, based on the joint utilization of dead-reckoning and computer vision (CV) techniques. The system is explicitly designed for visually impaired people (although it could be easily generalized to other users) and it is built under the assumption that special reference signals, such as painted lines, colored tapes or tactile pavings are deployed in the environment for guiding visually impaired users along pre-defined paths. Thanks to highly optimized software, we are able to execute the CV and sensor-fusion algorithms in run-time on low power hardware such as a normal smartphone, precisely tracking …

0301 basic medicineSensor FusionComputer scienceVisually impairedbusiness.industry05 social sciencesTracking systemSensor fusionNavigation03 medical and health sciencesComputer Networks and Communication030104 developmental biologySoftwareColoredHardware and ArchitectureLocalization0501 psychology and cognitive sciencesComputer visionArtificial intelligenceVisually ImpairedbusinessJoint (audio engineering)Software050107 human factorsProceedings of the 23rd Annual International Conference on Mobile Computing and Networking
researchProduct

Antibodies Responses to SARS-CoV-2 in a Large Cohort of Vaccinated Subjects and Seropositive Patients

2021

COVID-19 is a current global threat, and the characterization of antibody response is vitally important to update vaccine development and strategies. In this study we assessed SARS-CoV-2 antibody concentrations in SARS-CoV-2 positive patients (N = 272) and subjects vaccinated with the BNT162b2 m-RNA COVID-19 vaccine (N = 1256). For each participant, socio-demographic data, COVID-19 vaccination records, serological analyses, and SARS-CoV-2 infection status were collected. IgG antibodies against S1/S2 antigens of SARS-CoV-2 were detected. Almost all vaccinated subjects (99.8%) showed a seropositivity to anti-SARS-COV-2 IgG and more than 80% of vaccinated subjects had IgG concentrations &gt

0301 basic medicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)virusesImmunologyArticleSerologyPersistence (computer science)03 medical and health sciences0302 clinical medicineAntigenDrug DiscoveryMedicinePharmacology (medical)030212 general & internal medicineskin and connective tissue diseasesPharmacologyantibody concentrations.biologybusiness.industryImmunogenicitySARS-CoV-2 infectionfungiRantibody concentrationsrespiratory tract diseasesVaccinationbody regions030104 developmental biologyInfectious DiseasesImmunizationImmunologybiology.proteinMedicineAntibodybusinessCOVID-19 vaccineVaccines
researchProduct

Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning.

2021

Coronavirus disease 2019 (COVID-19) is a major threat worldwide due to its fast spreading. As yet, there are no established drugs available. Speeding up drug discovery is urgently required. We applied a workflow of combined in silico methods (virtual drug screening, molecular docking and supervised machine learning algorithms) to identify novel drug candidates against COVID-19. We constructed chemical libraries consisting of FDA-approved drugs for drug repositioning and of natural compound datasets from literature mining and the ZINC database to select compounds interacting with SARS-CoV-2 target proteins (spike protein, nucleocapsid protein, and 2′-o-ribose methyltransferase). Supported by…

0301 basic medicineSimeprevirArtificial intelligencevirusesMERS Middle East Respiratory SyndromeHealth InformaticsBiologyMachine learningcomputer.software_genremedicine.disease_causeAntiviral AgentsArticleWHO World Health OrganizationAUC area under the curve03 medical and health sciences0302 clinical medicinessRNA single-stranded RNA virusmedicineChemotherapyHumansSARS severe acute respiratory syndromeCOVID-19 coronavirus disease 2019CoronavirusNatural productsVirtual screeningACE2 angiotensin converting enzyme 2Drug discoverybusiness.industrySARS-CoV-2COVID-19LBE lowest binding energyFDA Food and Drug AdministrationROC receiver operating characteristicComputer Science ApplicationsHIV human immunodeficiency virusMolecular Docking SimulationDrug repositioning030104 developmental biologyDrug developmentSevere acute respiratory syndrome-related coronavirusParitaprevirInfectious diseasesRespiratory virusArtificial intelligenceSupervised Machine Learningbusinesscomputer030217 neurology & neurosurgeryComputers in biology and medicine
researchProduct

Screening of potent phytochemical inhibitors against SARS-CoV-2 protease and its two Asian mutants

2021

Abstract Background COVID-19, declared a pandemic in March 2020 by the World Health Organization is caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). The virus has already killed more than 2.3 million people worldwide. Object The principal intent of this work was to investigate lead compounds by screening natural product library (NPASS) for possible treatment of COVID-19. Methods Pharmacophore features were used to screen a large database to get a small dataset for structure-based virtual screening of natural product compounds. In the structure-based screening, molecular docking was performed to find a potent inhibitor molecule against the main protease (Mpro) of SARS-…

0301 basic medicineStereochemistrymedicine.medical_treatmentPhytochemicalsProtein Data Bank (RCSB PDB)Health Informaticsmedicine.disease_causeMolecular Docking SimulationAntiviral AgentsArticleDocking03 medical and health scienceschemistry.chemical_compound0302 clinical medicinemedicineHumansProtease InhibitorsCoronavirusVirtual screeningNatural productsProteaseChemistrySARS-CoV-2COVID-19Computer Science ApplicationsProteaseCoronavirusMolecular Docking Simulation030104 developmental biologyDocking (molecular)PharmacophoreLead compound030217 neurology & neurosurgeryMproPeptide HydrolasesComputers in Biology and Medicine
researchProduct

COVID 19-Induced Smell and Taste Impairments: Putative Impact on Physiology

2021

This article is part of the Research Topic "The Tribute of Physiology for the Understanding of COVID-19 Disease".; International audience; Smell and taste impairments are recognized as common symptoms in COVID 19 patients even in an asymptomatic phase. Indeed, depending on the country, in up to 85-90% of cases anosmia and dysgeusia are reported. We will review briefly the main mechanisms involved in the physiology of olfaction and taste focusing on receptors and transduction as well as the main neuroanatomical pathways. Then we will examine the current evidences, even if still fragmented and unsystematic, explaining the disturbances and mode of action of the virus at the level of the nasal …

0301 basic medicineTaste2019-20 coronavirus outbreakFood intakeCoronavirus disease 2019 (COVID-19)[SDV.MHEP.PHY] Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]PhysiologyAnosmiaPhysiologyfeeding behaviorOlfactionReviewlcsh:Physiologytaste03 medical and health sciences0302 clinical medicinePhysiology (medical)[SDV.MHEP.PHY]Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]medicinesmelllcsh:QP1-981business.industryCOVID-193. Good healthDysgeusia[SDV.AEN] Life Sciences [q-bio]/Food and Nutrition030104 developmental biologymedicine.symptomphysiopathologybusiness[SDV.AEN]Life Sciences [q-bio]/Food and NutritionTransduction (physiology)COVID 19030217 neurology & neurosurgeryFrontiers in Physiology
researchProduct